Literature DB >> 25268191

Anaplastic large cell lymphoma: features presenting diagnostic challenges.

Maria A Pletneva1, Lauren B Smith.   

Abstract

Anaplastic large cell lymphoma has histopathologic features that necessitate a broad differential diagnosis. Diagnostic considerations include carcinoma, melanoma, and hematopoietic malignancies, including diffuse large B-cell lymphoma, classical Hodgkin lymphoma, myeloid sarcoma, and peripheral T-cell lymphoma, not otherwise specified. Unusual features can include subtle sinusoidal involvement, histiocytic morphology, cytokeratin expression, CD15 expression, and variant patterns of anaplastic lymphoma kinase expression. Cases with unusual morphologic or immunohistochemical findings will be presented to highlight the complexity encountered in practice.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25268191     DOI: 10.5858/arpa.2014-0295-CC

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

Review 1.  Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma presenting in nasal cavity: a case report and review of literature.

Authors:  Ji Chen; Xiaoli Feng; Mei Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 2.  Successful Chemo-Radiotherapy for Primary Anaplastic Large Cell Lymphoma of the Lung: A Case Report and Literature Review.

Authors:  Qian Zhao; Yongmei Liu; Huijiao Chen; Yan Zhang; Zedong Du; Jin Wang; Yongsheng Wang
Journal:  Am J Case Rep       Date:  2016-02-08

3.  Primary Pulmonary Anaplastic Large Cell Lymphoma: A Rare Malignancy and Rare Cause of the Luftsichel Sign.

Authors:  Elizabeth Von Ende; Travis Kauffman; Philip A Munoz; Santiago Martinez-Jiménez
Journal:  Case Rep Radiol       Date:  2018-05-06

4.  Anaplastic Large Cell Lymphoma Presenting as Ulcerative Facial Mass: A Case Report.

Authors:  Hanna M Knauss; Logan D Glosser; Azizullah Beran; Alena N Sidwell; Waleed Abdulsattar; Roland T Skeel; Basil E Akpunonu
Journal:  Case Rep Oncol       Date:  2022-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.